Funding

Oncostellae’s R&D projects were initiated using private funds provided by the founders and a subvention granted by the Galician Agency for Innovation (GAIN) and the European Union (ERDF) for the development of the project Oncogalfarma within the framework Conecta Peme 2014/15.

In 2015 Inveready entered the company as a financial partner.

In 2016 Oncostellae has received funding from the project Neogalfarm with Galchimia, Nanogap, AMSLAB and several researcher groups from University of Santiago de Compostela (USC), The Health Research Institute of Santiago de Compostela (IDIS) and LEITAT.